Biopredic International

is the exclusive worldwide licensor of HepaRG™

Biopredic International is the exclusive worldwide licensor of HepaRG™, the human hepatic stem cell line patented by INSERM, and provider of primary hepatocyte cryopreservation and the isolation, production and distribution of fresh and frozen human and animal biological products, including tissues, primary cells, cell lines, and reagents.

Biopredic International is a major worldwide supplier of human and animal skin products, which can be used for several applications such as:

  • Compound penetration
  • Skin irritation
  • Toxicology e.g. genotoxicity and sensitization
  • Metabolism
  • Primary cell isolation…


Human skin samples are collected from patients who have undergone cosmetic surgery.

The collection, processing and sales to Research Bodies comply with the French Law and ethical principles.

Biopredic International holds a permit (AC-2013-1754) which has been granted by the French Ministry of Higher Education and Research.

The anonymity of patients is maintained and patients sign an informed consent form before donating their samples.

Biopredic International is also the exclusive worldwide licensor of HepaRG™, the human hepatic stem cell line patented by the INSERM.

Biopredic International is involved in several European and National Research projects and is always keen to examine new scientific collaborations.


SaferWorldbyDesign integrates in silico and in vitro methods to develop standard and premium Integrated Approaches to Testing and Assessment (IATAs), including methods that support ingredient and formulation screening and testing, product design and the preparation of Regulatory Dossiers.


Edelweiss Connect GmbH is registered as a limited company with Handelsregisteramt of Kanton Basel-Stadt

Swiss ID (UID) number: CHE-114.414.615

Copyright | SaferWorldbyDesign 2023